Centessa Pharmaceuticals Statistics
Total Valuation
CNTA has a market cap or net worth of $881.23 million. The enterprise value is $736.59 million.
| Market Cap | 881.23M |
| Enterprise Value | 736.59M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CNTA has 100.48 million shares outstanding.
| Shares Outstanding | 100.48M |
| Owned by Insiders (%) | 1.90% |
| Owned by Institutions (%) | 77.36% |
| Float | 71.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 128.59 |
| Forward PS | n/a |
| PB Ratio | 4.10 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 107.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.37, with a Debt / Equity ratio of 0.40.
| Current Ratio | 10.37 |
| Quick Ratio | n/a |
| Debt / Equity | 0.40 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.22 |
Financial Efficiency
Return on equity (ROE) is -56.10% and return on invested capital (ROIC) is -54.58%.
| Return on Equity (ROE) | -56.10% |
| Return on Assets (ROA) | -38.00% |
| Return on Capital (ROIC) | -54.58% |
| Revenue Per Employee | $89,000 |
| Profits Per Employee | -$1.80M |
| Employee Count | 77 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -25.25M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.96% in the last 52 weeks. The beta is 1.40, so CNTA's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | +44.96% |
| 50-Day Moving Average | 9.01 |
| 200-Day Moving Average | 8.42 |
| Relative Strength Index (RSI) | 45.59 |
| Average Volume (20 Days) | 248,929 |
Short Selling Information
| Short Interest | 1.06M |
| Short Previous Month | 1.25M |
| Short % of Shares Out | 1.20% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.71 |
Income Statement
In the last 12 months, CNTA had revenue of $6.85 million and -$138.42 million in losses. Loss per share was -$1.41.
| Revenue | 6.85M |
| Gross Profit | 6.85M |
| Operating Income | -164.12M |
| Pretax Income | -163.67M |
| Net Income | -138.42M |
| EBITDA | -152.62M |
| EBIT | -153.58M |
| Loss Per Share | -$1.41 |
Balance Sheet
The company has $230.18 million in cash and $85.54 million in debt, giving a net cash position of $144.63 million or $1.44 per share.
| Cash & Cash Equivalents | 230.18M |
| Total Debt | 85.54M |
| Net Cash | 144.63M |
| Net Cash Per Share | $1.44 |
| Equity (Book Value) | 215.16M |
| Book Value Per Share | 2.14 |
| Working Capital | 257.04M |
Cash Flow
In the last 12 months, operating cash flow was -$149.79 million and capital expenditures -$81,000, giving a free cash flow of -$149.87 million.
| Operating Cash Flow | -149.79M |
| Capital Expenditures | -81,000 |
| Free Cash Flow | -149.87M |
| FCF Per Share | -$1.50 |
Margins
Gross margin is 100.00%, with operating and profit margins of -2,394.79% and -2,019.80%.
| Gross Margin | 100.00% |
| Operating Margin | -2,394.79% |
| Pretax Margin | -2,388.28% |
| Profit Margin | -2,019.80% |
| EBITDA Margin | -2,227.02% |
| EBIT Margin | -2,241.05% |
| FCF Margin | -2,186.94% |
Dividends & Yields
CNTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.21% |
| Shareholder Yield | -5.21% |
| Earnings Yield | -15.71% |
| FCF Yield | -17.01% |
Analyst Forecast
The average price target for CNTA is $10.50, which is 19.73% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.50 |
| Price Target Difference | 19.73% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 96.21% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CNTA has an Altman Z-Score of 0.72. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.72 |
| Piotroski F-Score | n/a |